CD4 and diabetes mellitus: There was no significant enrichment for genomic regions associated with control conditions (ones in which CD4+ cells would not be expected to play a dominant role), such as coronary heart disease, atopic dermatitis and type 2 diabetes mellitus (P>0.05 for all).